Jenburkt Pharmaceuticals (BOM:524731) FFO


BOM:524731 Jenburkt Pharmaceuticals Ltd BOM:524731
84 GF Score
Price ₹1,103.15
GF Value ₹1,113.24
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Jenburkt Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

BOM:524731
84GF Score
Jenburkt Pharmaceuticals Ltd BOM:524731
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jenburkt Pharmaceuticals (BOM:524731) Overvalued in 2026?

Based on GuruFocus' analysis, Jenburkt Pharmaceuticals stock appears to be undervalued. The current stock price of ₹1,103.15 is trading 0.9% below its estimated GF Value™ of ₹1,113.24. GuruFocus considers Jenburkt Pharmaceuticals to be Fairly Valued.

Key valuation signals for BOM:524731:

  • FFO:
  • GF Value™: ₹1,113.24 vs. price of ₹1,103.15 (0.9% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the BOM:524731 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jenburkt Pharmaceuticals Business Description

Address 93, Jayprakash Road, Nirmala Apartments, Andheri (West, Mumbai, MH, IND, 400058
Jenburkt Pharmaceuticals Ltd is engaged in the manufacturing, producing, developing, and marketing of pharmaceutical formulations. The company operates in one segment - pharmaceutical formulations. The company generates key revenue from the local market.
84GF Score

Get the complete analysis for BOM:524731

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,103.15
Price
₹1,113.24
GF Value